Skip to content

Insider · CIK 0002052524

Gentilcore Douglas J

Reports to the SEC for 1 company · NEW YORK, NY

Transactions

2

Companies

1

Filings

2

CIK

0002052524

Forms 4 and 5

Insider transactions

2 trades
DateCompanyValue
2025-09-16Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer—
2025-01-17Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award—

Recent filings

2

Companies

1

Address

C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE

NEW YORK, NY, 10169